ImpacC

Languages:
English, Spanish, Chinese, Russian

Module:
PROMIS Survey API

Participants:
COVID-19 Patients

Status:
Launched July, 2020

The study

Client: Drexel University College of Medicine with National Institute of Allergy and Infectious Diseases (NIAID), Boston Children’s Hospital

Long-term consequences of the COVID-19 infection and recovery are still unknown, and are the subject of a new study, Immunophenotyping Assessment in a COVID-19 Cohort (IMPACC). The RESPOND HEALTH mobile app containing a COVID-19 symptom tracker and other life-impact surveys is in use over the course of this ground-breaking one-year follow-up study of COVID-19 patients post-hospitalization.

Highlights:

First controlled study correlating COVID-19 symptoms and patient-reported outcomes with immune status
Ability to support patients at home during COVID-19 recovery
Nationwide multi-site distributed data collection direct from recovering COVID-19 patient